
Tactile Systems Technology, Inc. (NASDAQ:TCMD – Free Report) – Stock analysts at William Blair boosted their FY2025 earnings estimates for Tactile Systems Technology in a research note issued on Tuesday, November 4th. William Blair analyst B. Vazquez now expects that the company will post earnings per share of $0.78 for the year, up from their previous estimate of $0.60. William Blair currently has a “Strong-Buy” rating on the stock. The consensus estimate for Tactile Systems Technology’s current full-year earnings is $0.70 per share. William Blair also issued estimates for Tactile Systems Technology’s Q1 2026 earnings at ($0.06) EPS, Q1 2027 earnings at ($0.01) EPS and Q2 2027 earnings at $0.27 EPS.
Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) last released its quarterly earnings results on Monday, November 3rd. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.20. The business had revenue of $85.76 million for the quarter, compared to analysts’ expectations of $79.31 million. Tactile Systems Technology had a net margin of 5.06% and a return on equity of 7.72%. Tactile Systems Technology has set its FY 2025 guidance at EPS.
Check Out Our Latest Analysis on TCMD
Tactile Systems Technology Stock Performance
NASDAQ:TCMD opened at $24.21 on Thursday. The stock has a market cap of $539.69 million, a P/E ratio of 39.05 and a beta of 1.06. The firm’s fifty day simple moving average is $14.58 and its 200 day simple moving average is $12.23. Tactile Systems Technology has a twelve month low of $8.61 and a twelve month high of $24.59. The company has a quick ratio of 3.36, a current ratio of 3.79 and a debt-to-equity ratio of 0.11.
Insider Activity
In other news, CEO Sheri Louise Dodd sold 7,762 shares of Tactile Systems Technology stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $12.36, for a total value of $95,938.32. Following the completion of the transaction, the chief executive officer owned 173,479 shares of the company’s stock, valued at $2,144,200.44. The trade was a 4.28% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 2.50% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Tactile Systems Technology
Several large investors have recently modified their holdings of TCMD. Acadian Asset Management LLC raised its position in shares of Tactile Systems Technology by 248.3% in the 2nd quarter. Acadian Asset Management LLC now owns 683,662 shares of the company’s stock worth $6,930,000 after purchasing an additional 487,392 shares during the last quarter. Federated Hermes Inc. raised its position in shares of Tactile Systems Technology by 42.7% in the 2nd quarter. Federated Hermes Inc. now owns 551,561 shares of the company’s stock worth $5,593,000 after purchasing an additional 165,163 shares during the last quarter. Norges Bank purchased a new position in shares of Tactile Systems Technology in the 2nd quarter worth about $1,464,000. Paradigm Capital Management Inc. NY raised its position in shares of Tactile Systems Technology by 5.9% in the 2nd quarter. Paradigm Capital Management Inc. NY now owns 1,618,600 shares of the company’s stock worth $16,413,000 after purchasing an additional 89,600 shares during the last quarter. Finally, Victory Capital Management Inc. purchased a new position in shares of Tactile Systems Technology in the 1st quarter worth about $1,160,000. Hedge funds and other institutional investors own 83.43% of the company’s stock.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Featured Stories
- Five stocks we like better than Tactile Systems Technology
- Do ETFs Pay Dividends? What You Need to Know
- Uber Stock Pullback Looks Like a Clear Buying Opportunity
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 Cash-Rich Stocks With High Growth Potential Right Now
- 3 Tickers Leading a Meme Stock Revival
- Why Vertical Aerospace Stock Could Double After This Flight Test
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.
